Hyperglycemia and its associated factors among people living with HIV on dolutegravir-based antiretroviral therapy in Ethiopia: a cross-sectional study

Background: In many low- and middle-income countries, including Ethiopia, dolutegravir (DTG)-based regimens are the preferred first-line regimens for people living with HIV (PLWH). However, there are concerns about hyperglycemia and, in certain circumstances, diabetes mellitus in individuals who hav...

Full description

Saved in:
Bibliographic Details
Main Authors: Enyew Fenta Mengistu, Adane Adugna, Mamaru Getinet, Gashaw Azanaw Amare, Baye Ashenef, Gelagey Baye, Desalegn Abebaw, Zigale Hibstu Teffera, Habtamu Belew, Temesgen Baylie, Muluken Getinet Mekuriaw, Dagmawi Abiy Abate, Bantayehu Addis Tegegne, Nuredin Chura Waritu, Mohammed Jemal
Format: Article
Language:English
Published: SAGE Publishing 2025-04-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/20499361251332031
Tags: Add Tag
No Tags, Be the first to tag this record!